Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers.
Journal: Journal for immunotherapy of cancer
Published: March 21, 2020
Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026